Evaxion A/S
EVAX
Positions held
Your positionsEVAX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $27.52M | Enterprise value | $18.54M | Trailing P/E | — | Forward P/E | -203.33 |
| PEG | — | Price / book | 2.67 | Beta | 0.51 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 100.0% | Operating margin | -116.0% |
| Profit margin | -115.5% | ROE | -109.9% | ROA | -26.0% | Debt / equity | 0.75 |
| Current ratio | 5.06 | Free cash flow | -$5.49M | Analyst recommendation | none | Mean target | $11.25 |
| 52w high | $12.15 | 52w low | $2.77 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $7.5M | $0.0M |
| Op margin | — | — | — | 40.3% | -11729.7% |
| Net income | -$3.7M | -$3.6M | -$5.9M | $4.6M | -$4.8M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$3.8M | -$3.8M | -$4.1M | $3.0M | -$4.3M |
- Operating margin expanded to 40.3%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $7.5M | $3.3M | $0.1M | $0.0M |
| Op margin | -122.7% | -440.6% | -30406.8% | — |
| Net income | -$7.7M | -$10.6M | -$22.1M | -$23.2M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$9.2M | -$14.7M | -$22.2M | -$25.3M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-06 · European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
2026-10-02 · Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
2026-09-25 · European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Down for Week
2026-09-23 · European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
2026-09-22 · European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
2026-09-18 · European Equities Traded in the US as American Depositary Receipts Drop in Friday Trading
2026-09-16 · European Equities Traded in US as ADRs Rise in Wednesday Trading
2026-09-14 · Evaxion applies its AI-Immunology™ platform in autoimmune diseases
2026-09-10 · European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading
2026-09-09 · European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
2026-09-08 · European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
2026-09-03 · European Equities Traded in the US as American Depositary Receipts Edge Higher in Thursday Trading
Price (daily)
Full chart · RSI · MACD · patterns